speb/financial-data huggingface dataset:
Financial ratios for GAIA.L — annual report dated 2025-03-31
Total revenue: 1842879090909.0908
Gross profit: 339917792207.7922
Operating income: 150950649350.64935
Net income: 161855454545.45453
Capital expenditures: 102715064935.06493
Operating cash flow: 204250259740.25974
Depreciation & amortization: 49340649350.64935
Net tangible assets: 1060085714285.7142
Owner earnings: 108481038961.03896
Return on net tangible assets (%): 10.233232794211691
Capex to operating income (%): 68.04546080253286
Buffett classification: The Good
Book value: 1107019220779.2207
Debt to equity: 0.2533465320702089
Current ratio: 0.9818347533803268
Quick ratio: 0.6964438930368761
Effective tax rate (%): 22.569275530877864
Interest coverage ratio: 15.698541329011345
COGS to revenue (%): 81.55506816021712
R&D to revenue (%): 0.01141635451980875
SG&A to revenue (%): 0.4105729819003565
Free cash flow (dilution-adjusted): 101368051948.05194
Retained earnings: 867467012987.013
Inventory turnover: 18.51672021401874
Receivables turnover: 15.0376296569469
Capitalized R&D asset: 433540805.8889072
ROCI (R&D-adjusted, %): 10.444992139233209
Rosenberg metric: 425.8514530655984
FCF margin (%): 5.5005264560274085
Revenue growth (%): 9.580781382711196
Rule of 40 score: 15.081307838738605
Financial ratios for GAIA.L — quarterly report dated 2025-03-31
Total revenue: 473250519480.5195
Gross profit: 81777922077.92207
Operating income: 35587792207.792206
Net income: 32540389610.38961
Capital expenditures: 0
Depreciation & amortization: 10204025974.025974
Net tangible assets: 1060085714285.7142
Owner earnings: 42744415584.41559
Return on net tangible assets (%): 4.032165985107796
Capex to operating income (%): 0
Buffett classification: The Great
Book value: 1107019220779.2207
Debt to equity: 0.2533465320702089
Current ratio: 0.9818347533803268
Quick ratio: 0.6964438930368761
Effective tax rate (%): 22.66635802469136
Interest coverage ratio: 15.73324912441867
COGS to revenue (%): 82.71995091147738
Retained earnings: 867467012987.013
Inventory turnover: 4.823004134452921
Receivables turnover: 3.8616565145330233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.463172326062151
Revenue growth (%): 2.783545741862524
Rule of 40 score: 2.783545741862524
Financial ratios for GAIA.L — quarterly report dated 2025-06-30
Total revenue: 483707945205.4795
Gross profit: 86096849315.0685
Operating income: 36657808219.178085
Net income: 32633424657.53425
Capital expenditures: 0
Depreciation & amortization: 13598904109.58904
Owner earnings: 46232328767.12329
Capex to operating income (%): 0
Buffett classification: The Great
Effective tax rate (%): 21.3481068659949
Interest coverage ratio: 12.568194627089989
COGS to revenue (%): 82.2006543062892
Capitalized R&D asset: 0
Revenue growth (%): 2.209701900895744
Rule of 40 score: 2.209701900895744
Financial ratios for GAIA.L — quarterly report dated 2025-12-31
Total revenue: 475315810810.8108
Gross profit: 78081756756.75676
Operating income: 23447027027.027027
Net income: 23732027027.027027
Capital expenditures: 0
Depreciation & amortization: 16107297297.297298
Owner earnings: 39839324324.324326
Capex to operating income (%): 0
Buffett classification: The Great
Effective tax rate (%): 20.11928080419839
Interest coverage ratio: 6.8369453857672005
COGS to revenue (%): 83.5726573825596
Capitalized R&D asset: 0
Revenue growth (%): -1.7349589722169472
Rule of 40 score: -1.7349589722169472
Financial ratios for TCBIO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.74
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCBIO — annual report dated 2022-12-31
Total revenue: 976761000
Net income: 332478000
Capital expenditures: 11270000
Operating cash flow: 147970000
Depreciation & amortization: 45284000
Net tangible assets: 3053855000
Owner earnings: 366492000
Return on net tangible assets (%): 12.000962717614295
Buffett classification: The Gruesome
Stock price: 14.9
Book value: 3055351000
Debt to equity: 0.6976095381512631
Effective tax rate (%): 22.99382751792104
COGS to revenue (%): 0
SG&A to revenue (%): 49.30970831144978
Free cash flow (dilution-adjusted): 115268000
Retained earnings: 2263502000
Receivables turnover: 1.3581932860746257
Capitalized R&D asset: 0
FCF margin (%): 11.801044472496343
Rule of 40 score: 11.801044472496343
Financial ratios for TCBIO — annual report dated 2023-12-31
Total revenue: 1075542000
Net income: 189141000
Capital expenditures: 16381000
Operating cash flow: 373740000
Depreciation & amortization: 40473000
Net tangible assets: 3197646000
Owner earnings: 213233000
Return on net tangible assets (%): 6.668436718761239
Buffett classification: The Gruesome
Stock price: 15.51
Book value: 3199142000
Debt to equity: 0.7374311612301048
Effective tax rate (%): 23.29893144629859
COGS to revenue (%): 0
SG&A to revenue (%): 48.56425876441831
Free cash flow (dilution-adjusted): 333159000
Retained earnings: 2435393000
Receivables turnover: 1.3416268539423952
Capitalized R&D asset: 0
FCF margin (%): 30.975917258461315
Revenue growth (%): 10.11311876702694
Rule of 40 score: 41.089036025488255
Financial ratios for TCBIO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.75
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCBIO — annual report dated 2024-12-31
Total revenue: 932346000
Net income: 77508000
Capital expenditures: 64841000
Operating cash flow: 480088000
Depreciation & amortization: 54228000
Net tangible assets: 3366440000
Owner earnings: 66895000
Return on net tangible assets (%): 1.9871139839117882
Buffett classification: The Gruesome
Stock price: 17.53
Book value: 3367936000
Debt to equity: 0.4588406668060201
Effective tax rate (%): 27.603889371479813
COGS to revenue (%): 0
SG&A to revenue (%): 54.94505258777321
Free cash flow (dilution-adjusted): 390554000
Retained earnings: 2495651000
Capitalized R&D asset: 0
FCF margin (%): 41.889384413082695
Revenue growth (%): -13.313845484416229
Rule of 40 score: 28.575538928666468
Financial ratios for TCBIO — quarterly report dated 2024-12-31
Capital expenditures: 7406000
Buffett classification: The Gruesome
Stock price: 17.53
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCBIO — quarterly report dated 2025-03-31
Total revenue: 280478000
Net income: 47047000
Capital expenditures: 2416000
Operating cash flow: 368000
Depreciation & amortization: 9217000
Net tangible assets: 3428278000
Owner earnings: 53848000
Return on net tangible assets (%): 1.5707010925018334
Buffett classification: The Gruesome
Stock price: 17.79
Book value: 3429774000
Debt to equity: 0.411257709691659
Effective tax rate (%): 22.18234146018724
COGS to revenue (%): 0
SG&A to revenue (%): 50.624647922475205
Free cash flow (dilution-adjusted): -14798000
Retained earnings: 2538385000
Capitalized R&D asset: 0
FCF margin (%): -5.2759931260205795
Rule of 40 score: -5.2759931260205795
Financial ratios for TCBIO — quarterly report dated 2025-06-30
Total revenue: 307464000
Net income: 77328000
Capital expenditures: 5544000
Operating cash flow: 62997000
Depreciation & amortization: 14452000
Net tangible assets: 3508574000
Owner earnings: 86236000
Return on net tangible assets (%): 2.457864648144802
Buffett classification: The Gruesome
Stock price: 19.86
Book value: 3510070000
Debt to equity: 0.5328258410800925
Effective tax rate (%): 24.327709711512117
COGS to revenue (%): 0
SG&A to revenue (%): 41.91515104207322
Free cash flow (dilution-adjusted): 49826000
Retained earnings: 2611401000
Capitalized R&D asset: 0
FCF margin (%): 16.20547446205084
Revenue growth (%): 9.621431983970222
Rule of 40 score: 25.826906446021063
Financial ratios for TCBIO — quarterly report dated 2025-09-30
Total revenue: 340354000
Net income: 105210000
Capital expenditures: 4950000
Operating cash flow: 166295000
Depreciation & amortization: 12622000
Net tangible assets: 3635602000
Owner earnings: 112882000
Return on net tangible assets (%): 3.104905322419781
Buffett classification: The Gruesome
Stock price: 20.3
Book value: 3637098000
Debt to equity: 0.17057995137881904
Effective tax rate (%): 23.638580625494452
COGS to revenue (%): 0
SG&A to revenue (%): 37.744818630014635
Free cash flow (dilution-adjusted): 153108000
Retained earnings: 2712298000
Capitalized R&D asset: 0
FCF margin (%): 44.98492745788209
Revenue growth (%): 10.697187312986236
Rule of 40 score: 55.682114770868324
Financial ratios for TCBIO — annual report dated 2025-12-31
Total revenue: 1255779000
Net income: 330244000
Capital expenditures: 12569000
Operating cash flow: 360154000
Depreciation & amortization: 52166000
Net tangible assets: 3629886000
Owner earnings: 369841000
Return on net tangible assets (%): 10.188777278404887
Buffett classification: The Gruesome
Stock price: 19.42
Book value: 3631382000
Debt to equity: 0.2535054147429271
Effective tax rate (%): 23.680062859651958
COGS to revenue (%): 0
SG&A to revenue (%): 41.07904336670704
Free cash flow (dilution-adjusted): 310826000
Retained earnings: 2808645000
Capitalized R&D asset: 0
FCF margin (%): 24.751648180133607
Revenue growth (%): 34.69023302507867
Rule of 40 score: 59.441881205212276
Financial ratios for TCBIO — quarterly report dated 2025-12-31
Total revenue: 327483000
Net income: 100659000
Capital expenditures: 341000
Operating cash flow: 130494000
Depreciation & amortization: 15875000
Net tangible assets: 3629886000
Owner earnings: 116193000
Return on net tangible assets (%): 3.2010096184838863
Buffett classification: The Gruesome
Stock price: 19.42
Book value: 3631382000
Debt to equity: 0.2535054147429271
Effective tax rate (%): 23.90747250255131
COGS to revenue (%): 0
SG&A to revenue (%): 35.583831832492066
Free cash flow (dilution-adjusted): 122690000
Retained earnings: 2808645000
Capitalized R&D asset: 0
FCF margin (%): 37.46454014406855
Revenue growth (%): -3.7816508693889306
Rule of 40 score: 33.68288927467962
Financial ratios for 156A.T — annual report dated 2022-08-31
Total revenue: 30115058.02638218
Gross profit: 18068031.42795358
Operating income: 3008138.109997838
Net income: 1501340.7337994666
Capital expenditures: 186311.54040222015
Operating cash flow: 2501434.441000505
Depreciation & amortization: 586765.6599149427
Net tangible assets: 3603971.7436747644
Owner earnings: 1901794.8533121892
Return on net tangible assets (%): 52.76941631548524
Capex to operating income (%): 6.193583325944901
Buffett classification: The Great
Shares outstanding: 9442892
Book value: 7160650.183810279
Debt to equity: 0.9190686100320417
Current ratio: 1.9027125783450483
Quick ratio: 1.883497678195336
Effective tax rate (%): 80.06321985608447
Interest coverage ratio: 30.40575591985428
COGS to revenue (%): 40.003307912037315
Free cash flow (dilution-adjusted): 2126937.2161753047
Retained earnings: 3831384.704101492
Inventory turnover: 88.28286936770377
Receivables turnover: 8.155713287341243
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.87731181622675
FCF margin (%): 7.062703363586448
Rule of 40 score: 7.062703363586448
Financial ratios for 156A.T — annual report dated 2023-08-31
Total revenue: 31867926.07802875
Gross profit: 19407248.459958933
Operating income: 4883661.875427789
Net income: 2997015.742642026
Capital expenditures: 192539.35660506503
Operating cash flow: 3668624.229979466
Depreciation & amortization: 558644.7638603697
Net tangible assets: 6338720.054757016
Owner earnings: 3363121.1498973304
Return on net tangible assets (%): 53.05678624146544
Capex to operating income (%): 3.9425202136501176
Buffett classification: The Great
Shares outstanding: 9442892
Book value: 9801540.041067762
Debt to equity: 0.261770035719149
Current ratio: 1.8250828190971096
Quick ratio: 1.7903734978889252
Effective tax rate (%): 28.993338219936042
Interest coverage ratio: 137.13300019219682
COGS to revenue (%): 39.100999505144436
Free cash flow (dilution-adjusted): 3323093.7713894593
Retained earnings: 6635126.625598905
Inventory turnover: 56.78253953401329
Receivables turnover: 7.9301397511560765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 41.628383495275905
FCF margin (%): 10.427706413190649
Revenue growth (%): 5.820570062030014
Rule of 40 score: 16.248276475220663
Financial ratios for 2402.HK — annual report dated 2022-12-31
Total revenue: 106051232.78735633
Gross profit: 40724037.41091954
Operating income: -14905640.316091953
Net income: -23955947.586206894
Capital expenditures: 23564690.433908045
Operating cash flow: -47717203.15517241
Depreciation & amortization: 10840305.08045977
Net tangible assets: 296576945.50431037
Owner earnings: -36680332.93965517
Return on net tangible assets (%): -12.36789760488044
Buffett classification: The Gruesome
Shares outstanding: 44744962
Book value: 394240983.83477014
Debt to equity: 0.0993843674146714
Current ratio: 2.727493224621913
Quick ratio: 2.3620995919631884
Interest coverage ratio: -14.141834857660042
COGS to revenue (%): 61.599656750265744
R&D to revenue (%): 13.719320419893744
SG&A to revenue (%): 17.481446325868617
Free cash flow (dilution-adjusted): -71297455.37068966
Retained earnings: -35151297.35057471
Inventory turnover: 1.501062970477179
Receivables turnover: 0.6815267371799003
Capitalized R&D asset: 14549508.435344826
ROCI (R&D-adjusted, %): -1.1855584451311665
FCF margin (%): -67.22925655531833
Rule of 40 score: -67.22925655531833
Financial ratios for 2714.HK — annual report dated 2022-12-31
Total revenue: 17934800600.25
Gross profit: 3137809296.9468393
Operating income: 2548831388.7830462
Net income: 2145603533.2729886
Capital expenditures: 2254786592.320402
Operating cash flow: 3306113620.966954
Depreciation & amortization: 1742892416.9698277
Net tangible assets: 10176867810.56178
Owner earnings: 1633709357.9224138
Return on net tangible assets (%): 16.053164768701365
Capex to operating income (%): 88.46354459707759
Buffett classification: The Gruesome
Shares outstanding: 310223100
Book value: 12653789779.896553
Debt to equity: 0.7131736463924965
Current ratio: 0.800570656917386
Quick ratio: 0.31121283617033774
Effective tax rate (%): -0.022561259865586335
Interest coverage ratio: 7.21805507878859
COGS to revenue (%): 82.5043535922942
R&D to revenue (%): 0.9151955316270685
SG&A to revenue (%): 2.1471896366474574
Free cash flow (dilution-adjusted): 1044774691.9410919
Retained earnings: 6866074563.21839
Inventory turnover: 2.692351138242181
Receivables turnover: 706.866238306526
Capitalized R&D asset: 164138493.69971266
ROCI (R&D-adjusted, %): 15.960158661106707
FCF margin (%): 5.825404559705717
Rule of 40 score: 5.825404559705717
Financial ratios for 2714.HK — annual report dated 2023-12-31
Total revenue: 15592226120.168776
Gross profit: 484661282.98734176
Operating income: -63940899.04922644
Net income: -586198169.1758087
Capital expenditures: 2385045574.734177
Operating cash flow: 1391394776.8945146
Depreciation & amortization: 1902658952.9057665
Net tangible assets: 8674101763.800282
Owner earnings: -1068584791.0042193
Return on net tangible assets (%): -12.319255873429515
Buffett classification: The Gruesome
Shares outstanding: 310223100
Book value: 10413031726.89592
Debt to equity: 1.0638251214256562
Current ratio: 0.6717034015791803
Quick ratio: 0.22873659095245485
Interest coverage ratio: -0.14034257531744812
COGS to revenue (%): 96.89164793242432
R&D to revenue (%): 1.4953263170079956
SG&A to revenue (%): 2.0300292914978546
Free cash flow (dilution-adjusted): -1001815547.0942334
Retained earnings: 5524545241.237693
Inventory turnover: 2.561714846774457
Receivables turnover: 660.5262241024791
Capitalized R&D asset: 343127451.36108595
ROCI (R&D-adjusted, %): 0.2534522340868421
Rosenberg metric: -16.164081649325762
FCF margin (%): -6.425096322829554
Revenue growth (%): -13.061614301129005
Rule of 40 score: -19.486710623958558
Financial ratios for 2714.HK — quarterly report dated 2024-12-31
Total revenue: 5639968015.1452055
Gross profit: 1311041836.1054795
Operating income: 1169620896.9753425
Net income: 1051971677.5465754
Capital expenditures: 297684827.7315069
Net tangible assets: 9704817421.186302
Owner earnings: 754286849.8150685
Return on net tangible assets (%): 7.772293048691539
Capex to operating income (%): 25.451394422015234
Buffett classification: The Good
Shares outstanding: 310223100
Book value: 10621401248.787672
Debt to equity: 0.9812180344653015
Current ratio: 0.717373688199681
Quick ratio: 0.22636350181729153
Effective tax rate (%): 0.04882670703005072
COGS to revenue (%): 76.75444554676743
R&D to revenue (%): 1.164806235863104
SG&A to revenue (%): -2.737274686892397
Free cash flow (dilution-adjusted): 842404425.760274
Retained earnings: 7160465312.554795
Inventory turnover: 0.7529493147711387
Receivables turnover: 178.0874056278361
Capitalized R&D asset: 65694699.14109589
ROCI (R&D-adjusted, %): 8.629121233576818
FCF margin (%): 14.936333388737943
Rule of 40 score: 14.936333388737943
Financial ratios for 2714.HK — annual report dated 2024-12-31
Total revenue: 18896834531.078083
Gross profit: 3921626553.4136987
Operating income: 3136021237.9616437
Net income: 2592471904.691781
Capital expenditures: 1677190338.3958905
Operating cash flow: 5142885782.8068495
Depreciation & amortization: 2068133008.1287673
Net tangible assets: 9704817421.186302
Owner earnings: 2983414574.424658
Return on net tangible assets (%): 30.741583740788908
Capex to operating income (%): 53.481472577208486
Buffett classification: The Good
Shares outstanding: 310223100
Book value: 10621401248.787672
Debt to equity: 0.9812180344653015
Current ratio: 0.717373688199681
Quick ratio: 0.22636350181729153
Effective tax rate (%): -0.15117098664299522
Interest coverage ratio: 7.204778580757335
COGS to revenue (%): 79.2471773673833
R&D to revenue (%): 1.2665871850932127
SG&A to revenue (%): 1.2703044572280158
Free cash flow (dilution-adjusted): 3446895945.5465755
Retained earnings: 7160465312.554795
Inventory turnover: 2.6047042890065906
Receivables turnover: 596.6856952346672
Capitalized R&D asset: 449724210.06993586
ROCI (R&D-adjusted, %): 21.896521567228994
Rosenberg metric: 14.741139044113075
FCF margin (%): 18.240599714612237
Revenue growth (%): 21.19394873727971
Rule of 40 score: 39.43454845189195
Financial ratios for 2714.HK — quarterly report dated 2025-03-31
Total revenue: 4967112546.849862
Gross profit: 983422623.469697
Operating income: 740418874.4683197
Net income: 636266810.9407715
Capital expenditures: 393540671.5909091
Net tangible assets: 10353370158.71901
Owner earnings: 242726139.34986234
Return on net tangible assets (%): 2.344416703245681
Capex to operating income (%): 53.15108584630599
Buffett classification: The Good
Shares outstanding: 310223100
Book value: 11137108564.176308
Debt to equity: 1.04944924503171
Current ratio: 0.7961130404580723
Quick ratio: 0.3340468209230601
Effective tax rate (%): -0.2238411962816597
Interest coverage ratio: 7.1594830143509665
COGS to revenue (%): 80.20132191098867
R&D to revenue (%): 1.4240628353001097
SG&A to revenue (%): 3.537869486593924
Free cash flow (dilution-adjusted): 639002630.4820937
Retained earnings: 7818525055.666667
Inventory turnover: 0.6755884795499756
Receivables turnover: 156.57020769941965
Capitalized R&D asset: 114750252.19175188
ROCI (R&D-adjusted, %): 5.2266077938248685
Rosenberg metric: -4.986996164365374
FCF margin (%): 12.864669855072009
Revenue growth (%): -11.930129151238107
Rule of 40 score: 0.9345407038339015
Financial ratios for 2714.HK — quarterly report dated 2025-06-30
Total revenue: 5634799942.762901
Gross profit: 1114214467.818689
Operating income: 972667289.6401674
Net income: 860665212.4002789
Capital expenditures: 325242019.6834031
Net tangible assets: 10769699748.828453
Owner earnings: 535423192.71687585
Return on net tangible assets (%): 4.97157028704649
Capex to operating income (%): 33.43815744063157
Buffett classification: The Good
Shares outstanding: 310223100
Book value: 11427310367.348673
Debt to equity: 0.943454909675936
Current ratio: 0.7933079371430249
Quick ratio: 0.30677170814295046
Effective tax rate (%): -0.16039659821593671
Interest coverage ratio: 10.060171735138304
COGS to revenue (%): 80.22619295917082
R&D to revenue (%): 1.0086954207351653
SG&A to revenue (%): -0.1863185794677428
Free cash flow (dilution-adjusted): 1044048348.0864714
Retained earnings: 8328949646.549512
Inventory turnover: 0.8276408732906608
Receivables turnover: 119.66748342981104
Capitalized R&D asset: 125909538.23083457
ROCI (R&D-adjusted, %): 6.475182801277342
Rosenberg metric: 1.8490451288932277
FCF margin (%): 18.528578808328465
Revenue growth (%): 13.442163623541928
Rule of 40 score: 31.97074243187039
Financial ratios for 2714.HK — quarterly report dated 2025-12-31
Total revenue: 4622137213.28
Gross profit: 678482457.4785715
Operating income: 169341612.13142857
Net income: 101140899.56428573
Capital expenditures: 111942668.23
Net tangible assets: 10920582761.61
Owner earnings: -10801768.665714279
Return on net tangible assets (%): -0.09891201689058758
Capex to operating income (%): 66.10464304728575
Buffett classification: The Good
Shares outstanding: 310223100
Book value: 11248854133.045713
Debt to equity: 0.8921378583418894
Current ratio: 0.7814420556892079
Quick ratio: 0.24912206599404102
Effective tax rate (%): 1.930215434499794
Interest coverage ratio: 2.2274954133256157
COGS to revenue (%): 85.32102302092628
R&D to revenue (%): 1.189453811614876
SG&A to revenue (%): -2.196036785501874
Free cash flow (dilution-adjusted): -109385492.59857143
Retained earnings: 8489788277.604286
Inventory turnover: 0.7425359159819038
Receivables turnover: 54.96523570387468
Capitalized R&D asset: 73734717.02820683
ROCI (R&D-adjusted, %): 1.278436534844983
FCF margin (%): -2.3665565852154438
Rule of 40 score: -2.3665565852154438
Financial ratios for 2714.HK — annual report dated 2025-12-31
Total revenue: 20592137910.239998
Gross profit: 3669130006.6157146
Operating income: 2713926153.5457144
Net income: 2258831077.6357145
Capital expenditures: 1143974755.1657143
Operating cash flow: 4293740987.781429
Depreciation & amortization: 2189687662.437143
Net tangible assets: 10920582761.61
Owner earnings: 3304543984.9071426
Return on net tangible assets (%): 30.259776946372046
Capex to operating income (%): 42.15202221590017
Buffett classification: The Good
Shares outstanding: 310223100
Book value: 11248854133.045713
Debt to equity: 0.8921378583418894
Current ratio: 0.7814420556892079
Quick ratio: 0.24912206599404102
Effective tax rate (%): -0.011889629635054235
Interest coverage ratio: 7.430085211531266
COGS to revenue (%): 82.18188891989142
R&D to revenue (%): 1.1434287709946054
SG&A to revenue (%): 1.5795067338767539
Free cash flow (dilution-adjusted): 2932465323.2200003
Retained earnings: 8489788277.604286
Inventory turnover: 3.1863694854122713
Receivables turnover: 244.87626862981872
Capitalized R&D asset: 472758540.0751891
ROCI (R&D-adjusted, %): 18.05320840587336
Rosenberg metric: -1.0549485829342775
FCF margin (%): 14.240703592810306
Revenue growth (%): 8.971361718671917
Rule of 40 score: 23.21206531148222
Financial ratios for 5130.T — annual report dated 2022-08-31
Total revenue: 13023693.505370144
Gross profit: 3060397.8951921
Operating income: 156000.86498954805
Net income: 41108.628270741734
Capital expenditures: 180040.36617890868
Operating cash flow: -208166.9429827723
Depreciation & amortization: 88820.01009154474
Net tangible assets: -58567.00064874216
Owner earnings: -50111.72781662221
Capex to operating income (%): 115.40985121522964
Buffett classification: The Gruesome
Shares outstanding: 300000
Book value: 22338.35507820919
Debt to equity: 210.7150693772211
Current ratio: 3.7833415633466343
Quick ratio: 3.209431595243497
Effective tax rate (%): 44.90387402183364
Interest coverage ratio: 2.130957069712485
COGS to revenue (%): 76.50125056938406
Free cash flow (dilution-adjusted): -393613.4938369495
Retained earnings: -352490.4490737404
Inventory turnover: 16.07124004418348
Receivables turnover: 29.208933507929576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9917000968322034
FCF margin (%): -3.0222877532755845
Rule of 40 score: -3.0222877532755845
Financial ratios for 559A.T — annual report dated 2024-06-30
Total revenue: 16794312.02937333
Gross profit: 9692849.586159686
Operating income: 2630381.479868069
Net income: 1973800.4854066838
Capital expenditures: 671616.1553301387
Operating cash flow: 3550127.5748335305
Depreciation & amortization: 1167820.026137283
Net tangible assets: 18222073.557782065
Owner earnings: 2470004.356213828
Return on net tangible assets (%): 13.555012542241485
Capex to operating income (%): 25.533032393606454
Buffett classification: The Good
Shares outstanding: 6023920
Book value: 18360240.214076795
Debt to equity: 0.9209122982794671
Current ratio: 4.501640833676249
Quick ratio: 3.377440417457585
Effective tax rate (%): 27.37069409682228
Interest coverage ratio: 43.024837133550484
COGS to revenue (%): 42.28488911978383
Free cash flow (dilution-adjusted): 2583241.023087933
Retained earnings: 12502682.183085443
Inventory turnover: 1.497121558399303
Receivables turnover: 7.394509490159115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.693787700926746
FCF margin (%): 15.381642418991815
Rule of 40 score: 15.381642418991815
Financial ratios for 559A.T — annual report dated 2025-06-30
Total revenue: 18577788.541378353
Gross profit: 10346671.74093551
Operating income: 2193592.5823415443
Net income: 1672412.1228895653
Capital expenditures: 1615416.5513423746
Operating cash flow: 1731926.3769720453
Depreciation & amortization: 1495543.869360642
Net tangible assets: 21987890.94934957
Owner earnings: 1552539.4409078327
Return on net tangible assets (%): 7.060883849588852
Capex to operating income (%): 73.64250610375436
Buffett classification: The Good
Shares outstanding: 6023920
Book value: 22092900.63659009
Debt to equity: 0.7763727008900467
Current ratio: 5.130710059171597
Quick ratio: 3.497891339429801
Effective tax rate (%): 21.409061644414674
Interest coverage ratio: 35.018005081188555
COGS to revenue (%): 44.306187804065914
Free cash flow (dilution-adjusted): 110905.06504290063
Retained earnings: 15573989.759202877
Inventory turnover: 1.3063144682266974
Receivables turnover: 8.827166054596443
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.760146230361878
FCF margin (%): 0.5969766788758604
Revenue growth (%): 10.6195270689607
Rule of 40 score: 11.21650374783656
Financial ratios for AGRZ — annual report dated 2021-12-31
Capital expenditures: 0
Net tangible assets: -140392.32613908872
Buffett classification: The Gruesome
Shares outstanding: 21673485
Book value: -138353.95683453238
Debt to equity: -0.1755290014837001
Current ratio: 0.26453365830478337
Quick ratio: 0.26453365830478337
Retained earnings: -188713.66906474822
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AGRZ — annual report dated 2022-12-31
Total revenue: 648108.5972850679
Gross profit: 62151.80995475113
Operating income: -25839.81900452489
Net income: -65580.31674208144
Capital expenditures: 6631.221719457014
Operating cash flow: -627343.4389140272
Depreciation & amortization: 21106.33484162896
Net tangible assets: 23008.823529411766
Owner earnings: -51105.203619909495
Return on net tangible assets (%): -222.11132852830406
Buffett classification: The Gruesome
Shares outstanding: 21673485
Book value: 36922.850678733084
Debt to equity: 0.16058921929668665
Current ratio: 3.161353724823731
Quick ratio: 3.161353724823731
Interest coverage ratio: -1.259936678838156
COGS to revenue (%): 90.41027842940125
SG&A to revenue (%): 13.356372877569259
Free cash flow (dilution-adjusted): -647549.3212669684
Retained earnings: -243620.13574660633
Receivables turnover: 2.0816259796316547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.2885266928982775
FCF margin (%): -99.91370643431637
Rule of 40 score: -99.91370643431637
Financial ratios for AGRZ — annual report dated 2023-12-31
Total revenue: 4006783.514099783
Gross profit: 1792515.8351409978
Operating income: 1363752.7114967462
Net income: 814400.2169197396
Capital expenditures: 47133.18872017353
Operating cash flow: -739541.6485900217
Depreciation & amortization: 64952.9284164859
Net tangible assets: 845190.672451193
Owner earnings: 832219.956616052
Return on net tangible assets (%): 98.4653503336089
Capex to operating income (%): 3.4561389556061015
Buffett classification: The Great
Shares outstanding: 21673485
Book value: 1163998.0477223424
Debt to equity: 0.679666964279558
Current ratio: 2.627041937601671
Quick ratio: 2.627041937601671
Effective tax rate (%): 26.532507988330156
Interest coverage ratio: 12.49356631711151
COGS to revenue (%): 55.26297268536785
SG&A to revenue (%): 8.852330256411145
Free cash flow (dilution-adjusted): -1156885.2494577006
Retained earnings: 580820.8242950108
Receivables turnover: 1.1616344171279658
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.43864868381218
FCF margin (%): -28.873165854522636
Revenue growth (%): 518.2271815069621
Rule of 40 score: 489.35401565243944
Financial ratios for AMBQ — annual report dated 2021-12-31
Total revenue: 91008000
Gross profit: 30766000
Operating income: -24465000
Net income: -25342000
Capital expenditures: 4623000
Operating cash flow: -52881000
Depreciation & amortization: 2611000
Net tangible assets: 88306000
Owner earnings: -27354000
Return on net tangible assets (%): -30.976377596086337
Buffett classification: The Gruesome
Shares outstanding: 24145438
Book value: 89006000
Debt to equity: 0
Current ratio: 6.677792041078305
Quick ratio: 4.402134990878995
COGS to revenue (%): 66.19418073136427
R&D to revenue (%): 39.673435302391
SG&A to revenue (%): 21.014636075949365
Free cash flow (dilution-adjusted): -58794000
Retained earnings: -158097000
Inventory turnover: 1.788551748708509
Receivables turnover: 4.39907192575406
Capitalized R&D asset: 36106000
ROCI (R&D-adjusted, %): -0.3118960803389469
FCF margin (%): -64.603111814346
Rule of 40 score: -64.603111814346
Financial ratios for AMBQ — annual report dated 2023-12-31
Total revenue: 65537000
Gross profit: 19441000
Operating income: -51322000
Net income: -50332000
Capital expenditures: 459000
Operating cash flow: -26958000
Depreciation & amortization: 8892000
Net tangible assets: 53576000
Owner earnings: -41899000
Return on net tangible assets (%): -78.20479319098104
Buffett classification: The Gruesome
Shares outstanding: 24145438
Book value: 59133000
Debt to equity: 0.017299984780072043
Current ratio: 4.944027250909654
Quick ratio: 3.2813346752341874
COGS to revenue (%): 70.33584082274135
R&D to revenue (%): 67.16816454827045
SG&A to revenue (%): 40.80595694035431
Free cash flow (dilution-adjusted): -32602000
Retained earnings: -277865000
Inventory turnover: 2.146296037621642
Receivables turnover: 5.339063136456212
Capitalized R&D asset: 68211020
ROCI (R&D-adjusted, %): -26.62782936998011
Rosenberg metric: -0.31365977953802693
FCF margin (%): -49.74594503868044
Revenue growth (%): -27.98764943741209
Rule of 40 score: -77.73359447609253
Financial ratios for AMBQ — annual report dated 2024-12-31
Total revenue: 76067000
Gross profit: 24291000
Operating income: -40613000
Net income: -39661000
Capital expenditures: 658000
Operating cash flow: -21428000
Depreciation & amortization: 6246000
Net tangible assets: 74019000
Owner earnings: -34073000
Return on net tangible assets (%): -46.03277536848647
Buffett classification: The Gruesome
Shares outstanding: 24145438
Book value: 85748000
Debt to equity: 0.011265568876242011
Current ratio: 7.559143439836846
Quick ratio: 6.283820530251529
COGS to revenue (%): 68.06630996358474
R&D to revenue (%): 48.862187282264316
SG&A to revenue (%): 36.46259218846543
Free cash flow (dilution-adjusted): -30333000
Retained earnings: -320250000
Inventory turnover: 3.449893390191898
Receivables turnover: 7.313431400826843
Capitalized R&D asset: 78576380
ROCI (R&D-adjusted, %): -24.86638620794946
Rosenberg metric: 0.11017719218537028
FCF margin (%): -39.87668765693402
Revenue growth (%): 16.067259715885683
Rule of 40 score: -23.809427941048334
Financial ratios for AMBQ — quarterly report dated 2025-03-31
Total revenue: 15732000
Gross profit: 8389000
Operating income: -8741000
Net income: -8284000
Capital expenditures: 116000
Operating cash flow: 1406000
Depreciation & amortization: 1961000
Net tangible assets: 67550000
Owner earnings: -6439000
Return on net tangible assets (%): -9.53219837157661
Buffett classification: The Gruesome
Shares outstanding: 24145438
Book value: 78433000
Debt to equity: 0.014088457664503461
Current ratio: 5.607785036029362
Quick ratio: 4.577816687992457
COGS to revenue (%): 46.675565725908974
R&D to revenue (%): 55.218662598525306
SG&A to revenue (%): 53.66768370200864
Free cash flow (dilution-adjusted): -561000
Retained earnings: -328534000
Inventory turnover: 0.48012292402249246
Receivables turnover: 3.878698224852071
Capitalized R&D asset: 8687000
ROCI (R&D-adjusted, %): -3.167155215301415
FCF margin (%): -3.5659801678108316
Rule of 40 score: -3.5659801678108316
Financial ratios for AMBQ — quarterly report dated 2025-06-30
Total revenue: 17873000
Gross profit: 7170000
Operating income: -8797000
Net income: -8496000
Capital expenditures: 338000
Operating cash flow: -11955000
Depreciation & amortization: 1853000
Net tangible assets: 61445000
Owner earnings: -6981000
Return on net tangible assets (%): -11.36138009602083
Buffett classification: The Gruesome
Shares outstanding: 24145438
Book value: 70839000
Debt to equity: 0.01232371998475416
Current ratio: 5.604055975454614
Quick ratio: 4.424754920302328
COGS to revenue (%): 59.88362334247188
R&D to revenue (%): 49.78459128294075
SG&A to revenue (%): 39.551278464723325
Free cash flow (dilution-adjusted): -14745000
Retained earnings: -337030000
Inventory turnover: 0.6791674598642046
Receivables turnover: 2.2952356491588546
Capitalized R&D asset: 14718290
ROCI (R&D-adjusted, %): -6.364091352882016
Rosenberg metric: -0.14032462299988488
FCF margin (%): -82.49874111788732
Revenue growth (%): 13.609204169844901
Rule of 40 score: -68.88953694804242
Financial ratios for CAVEN.OL — annual report dated 2022-12-31
Total revenue: 2075303.6437246962
Gross profit: 493623.48178137647
Operating income: -4243724.696356275
Net income: -7621457.489878542
Capital expenditures: 216700.4048582996
Operating cash flow: -3256882.5910931174
Depreciation & amortization: 475303.6437246963
Net tangible assets: -223076.92307692306
Owner earnings: -7362854.251012145
Buffett classification: The Gruesome
Shares outstanding: 33417965
Book value: 581578.9473684216
Debt to equity: 4.579881656804729
Current ratio: 1.200326574481718
Quick ratio: 0.7296252661168641
Interest coverage ratio: -18.601597160603372
COGS to revenue (%): 76.21439719079204
R&D to revenue (%): 7.925282871634802
SG&A to revenue (%): 19.659578618806083
Free cash flow (dilution-adjusted): -3748481.781376518
Inventory turnover: 0.6862073508101699
Receivables turnover: 0.8885422083550009
Capitalized R&D asset: 164473.6842105263
ROCI (R&D-adjusted, %): -115.01975913566686
FCF margin (%): -180.62329301599686
Rule of 40 score: -180.62329301599686
Financial ratios for CAVEN.OL — annual report dated 2023-12-31
Total revenue: 2837622.78978389
Gross profit: 1435559.9214145383
Operating income: -2363359.5284872297
Net income: -2837819.253438114
Capital expenditures: 121807.46561886051
Operating cash flow: -1847347.7406679764
Depreciation & amortization: 465225.93320235756
Net tangible assets: 1245579.5677799608
Owner earnings: -2494400.785854617
Return on net tangible assets (%): -200.26025236593063
Buffett classification: The Gruesome
Shares outstanding: 33417965
Book value: 2098526.5225933203
Debt to equity: 0.7867340729298319
Current ratio: 1.5744930560083459
Quick ratio: 0.6698832887787705
Interest coverage ratio: -11.066697332106715
COGS to revenue (%): 49.40976910028733
R&D to revenue (%): 4.157579534046457
SG&A to revenue (%): 13.892062173295946
Free cash flow (dilution-adjusted): -2268172.8880157173
Retained earnings: 1898330.0589390963
Inventory turnover: 0.5143794147325933
Receivables turnover: 2.8201698721077806
Capitalized R&D asset: 228173.79278254576
ROCI (R&D-adjusted, %): -57.328511325789734
Rosenberg metric: 5.726973552969624
FCF margin (%): -79.93214940976911
Revenue growth (%): 36.732896815571756
Rule of 40 score: -43.199252594197354
Financial ratios for CLUS.V — annual report dated 2022-05-31
Total revenue: 0
Operating income: -110653.54330708661
Net income: -110653.54330708661
Capital expenditures: 53799.2125984252
Operating cash flow: -87519.68503937007
Net tangible assets: 272157.48031496065
Owner earnings: -164452.75590551182
Return on net tangible assets (%): -60.42558731628284
Buffett classification: The Gruesome
Shares outstanding: 21045750
Book value: 272157.48031496065
Debt to equity: 0
Current ratio: 3.6370661294024638
Quick ratio: 3.6370661294024638
Free cash flow (dilution-adjusted): -141318.89763779528
Retained earnings: -261307.87401574804
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.65790996412452
Rule of 40 score: 0
Financial ratios for FFM.TO — annual report dated 2022-06-30
Operating income: -2401801.379310345
Net income: -2182104.827586207
Capital expenditures: 310780
Depreciation & amortization: 19781.37931034483
Net tangible assets: 39053528.27586207
Owner earnings: -2473103.4482758623
Return on net tangible assets (%): -6.332599274530646
Buffett classification: The Gruesome
Shares outstanding: 768785998
Book value: 51131086.89655173
Debt to equity: 0.0009611400991819863
Current ratio: 3.663962855083808
Quick ratio: 3.663962855083808
Free cash flow (dilution-adjusted): -18398581.379310347
Retained earnings: -26393899.31034483
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.434257432572774
Rule of 40 score: 0
Financial ratios for FFM.TO — annual report dated 2023-06-30
Operating income: -2573133.1125827814
Net income: -2303025.1655629138
Capital expenditures: 244239.0728476821
Depreciation & amortization: 167166.2251655629
Net tangible assets: 39465744.37086093
Owner earnings: -2380098.013245033
Return on net tangible assets (%): -6.030794683306039
Buffett classification: The Gruesome
Shares outstanding: 768785998
Book value: 53992123.841059595
Debt to equity: 0.02255375560234706
Current ratio: 3.0599094942147627
Quick ratio: 3.0599094942147627
Free cash flow (dilution-adjusted): -10618505.9602649
Retained earnings: -27648964.90066225
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.642414967531134
Rule of 40 score: 0
Financial ratios for FFM.TO — annual report dated 2024-06-30
Operating income: -16046000
Net income: -14966666.666666666
Capital expenditures: 756666.6666666666
Depreciation & amortization: 902000
Net tangible assets: 122723333.33333333
Owner earnings: -14821333.333333332
Return on net tangible assets (%): -12.077029633049948
Buffett classification: The Gruesome
Shares outstanding: 768785998
Book value: 151863333.33333334
Debt to equity: 0.008792993700476304
Current ratio: 3.3333790455293473
Quick ratio: 3.303666118120314
Interest coverage ratio: -27.88991888760139
Free cash flow (dilution-adjusted): -48212666.666666664
Retained earnings: -42800000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.472702370832152
Rule of 40 score: 0
Financial ratios for FNUC — annual report dated 2021-06-30
Total revenue: 0
Gross profit: 0
Operating income: -354811.29032258067
Net income: -445512.9032258065
Capital expenditures: 218267.74193548388
Operating cash flow: -293125.8064516129
Depreciation & amortization: 0
Net tangible assets: 3832956.4516129033
Owner earnings: -663780.6451612904
Return on net tangible assets (%): -17.31771945600823
Buffett classification: The Gruesome
Shares outstanding: 26318334
Book value: 3832956.451612903
Debt to equity: 0.09812584659445482
Current ratio: 0.289100601606466
Quick ratio: 0.289100601606466
Interest coverage ratio: -3.1366993669081165
Free cash flow (dilution-adjusted): -511393.5483870968
Retained earnings: -1831874.1935483871
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.256856810185688
Rule of 40 score: 0
Financial ratios for INDIQUBE.NS — annual report dated 2023-03-31
Total revenue: 70613641.90012181
Gross profit: 62669792.935444586
Operating income: 6186236.297198539
Net income: -24130207.06455542
Capital expenditures: 20570036.540803898
Operating cash flow: 39450548.11205847
Depreciation & amortization: 36315468.94031669
Net tangible assets: -38369549.33008526
Owner earnings: -8384774.665042628
Capex to operating income (%): 332.5129457165922
Buffett classification: The Gruesome
Shares outstanding: 211997634
Book value: -37527527.40560293
Debt to equity: -9.496275571971527
Current ratio: 0.25695716368257765
Quick ratio: 0.25695716368257765
Interest coverage ratio: 0.271639603790942
COGS to revenue (%): 11.249736950139546
SG&A to revenue (%): 0.7505114379254076
Free cash flow (dilution-adjusted): 18076248.47746651
Retained earnings: -53916930.572472595
Receivables turnover: 17.45515310270075
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9985684317559453
FCF margin (%): 25.59880497742084
Rule of 40 score: 25.59880497742084
Financial ratios for INDIQUBE.NS — annual report dated 2024-03-31
Total revenue: 99601031.29871687
Gross profit: 88756685.45389135
Operating income: 13106487.588439861
Net income: -40953111.88391893
Capital expenditures: 21954790.74229524
Operating cash flow: 65017148.33912939
Depreciation & amortization: 47037174.72118959
Net tangible assets: 14633888.955510253
Owner earnings: -15870727.905024584
Return on net tangible assets (%): -108.45188147371184
Capex to operating income (%): 167.5108650898943
Buffett classification: The Gruesome
Shares outstanding: 211997634
Book value: 15665307.590838194
Debt to equity: 23.337242503808433
Current ratio: 0.2692359079940955
Quick ratio: 0.2692359079940955
Interest coverage ratio: 0.43101646455683723
COGS to revenue (%): 10.887784698033768
SG&A to revenue (%): 0.7598368836935465
Free cash flow (dilution-adjusted): 40853819.40280609
Retained earnings: -94063316.94447775
Receivables turnover: 14.00936124276823
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.587333409481497
FCF margin (%): 41.0174662552238
Revenue growth (%): 41.05069306522351
Rule of 40 score: 82.06815932044731
Financial ratios for INDIQUBE.NS — quarterly report dated 2024-09-30
Capital expenditures: 4857859.531772575
Operating cash flow: 15967869.087434305
Depreciation & amortization: 14582417.582417583
Buffett classification: The Gruesome
Shares outstanding: 211997634
Free cash flow (dilution-adjusted): 10719302.436693741
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDIQUBE.NS — quarterly report dated 2024-12-31
Total revenue: 31226366.70940669
Gross profit: 29948828.534794264
Operating income: 4766056.649959202
Net income: -1599836.8108171115
Capital expenditures: 0
Depreciation & amortization: 13622333.605315303
Owner earnings: 12022496.794498192
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 211997634
Interest coverage ratio: 0.4739538657702561
COGS to revenue (%): 4.091216203605198
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDIQUBE.NS — annual report dated 2025-03-31
Total revenue: 123835164.83516483
Gross profit: 108896890.34369884
Operating income: 15327215.337853635
Net income: -16321837.736731352
Capital expenditures: 29477320.551788636
Operating cash flow: 71504325.46177226
Depreciation & amortization: 56948678.98059387
Net tangible assets: -1248655.5997194294
Owner earnings: 11149520.692073882
Capex to operating income (%): 192.32013057837372
Buffett classification: The Gruesome
Shares outstanding: 211997634
Book value: -363689.50198733807
Debt to equity: -1313.9762134363252
Current ratio: 0.26013132430019603
Quick ratio: 0.26013132430019603
Interest coverage ratio: 0.4033626630568546
COGS to revenue (%): 12.063031136067124
SG&A to revenue (%): 1.354497274579292
Free cash flow (dilution-adjusted): 40535071.31166705
Retained earnings: -108187982.23053542
Receivables turnover: 13.45176324177429
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3812731076486315
FCF margin (%): 32.73308624866183
Revenue growth (%): 24.331207438772935
Rule of 40 score: 57.06429368743476
Financial ratios for INDIQUBE.NS — quarterly report dated 2025-03-31
Total revenue: 34714051.90554126
Gross profit: 32734276.361935932
Operating income: 4626607.435118073
Net income: -3662613.9817629177
Capital expenditures: 0
Depreciation & amortization: 15242576.572363805
Net tangible assets: -1248655.5997194294
Owner earnings: 11579962.590600887
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 211997634
Book value: -363689.50198733807
Debt to equity: -1313.9762134363252
Current ratio: 0.26013132430019603
Quick ratio: 0.26013132430019603
Interest coverage ratio: 0.4342092270557902
COGS to revenue (%): 5.703095533164502
Retained earnings: -108187982.23053542
Receivables turnover: 3.770861112169352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.020656587330406
Revenue growth (%): 11.169039384540175
Rule of 40 score: 11.169039384540175
Financial ratios for RAL — annual report dated 2022-12-31
Total revenue: 2089700000
Gross profit: 1048200000
Operating income: 473800000
Net income: 370700000
Capital expenditures: 30800000
Operating cash flow: 391700000
Depreciation & amortization: 38300000
Owner earnings: 378200000
Capex to operating income (%): 6.500633178556353
Buffett classification: The Great
Shares outstanding: 111933148
Effective tax rate (%): 21.445221445221446
COGS to revenue (%): 49.839689907642246
R&D to revenue (%): 7.422118007369479
SG&A to revenue (%): 20.06508111212136
Free cash flow (dilution-adjusted): 340600000
Capitalized R&D asset: 155100000
ROCI (R&D-adjusted, %): 372.14700193423596
FCF margin (%): 16.29899028568694
Rule of 40 score: 16.29899028568694
Financial ratios for RAL — annual report dated 2023-12-31
Total revenue: 2155700000
Gross profit: 1119700000
Operating income: 511800000
Net income: 416800000
Capital expenditures: 22400000
Operating cash flow: 461800000
Depreciation & amortization: 30700000
Net tangible assets: 152400000
Owner earnings: 425100000
Return on net tangible assets (%): 278.93700787401576
Capex to operating income (%): 4.376709652207893
Buffett classification: The Great
Shares outstanding: 111933148
Book value: 2260700000
Debt to equity: 0.020834254876808067
Current ratio: 1.1038211968276856
Quick ratio: 0.611211247296323
Effective tax rate (%): 18.242448018830913
COGS to revenue (%): 48.05863524609176
R&D to revenue (%): 7.491766015679362
SG&A to revenue (%): 20.707890708354597
Free cash flow (dilution-adjusted): 407600000
Inventory turnover: 3.790706183680937
Receivables turnover: 7.28277027027027
Capitalized R&D asset: 265417000
ROCI (R&D-adjusted, %): 20.48577247286113
Rosenberg metric: 0.46099290780141844
FCF margin (%): 18.90801131882915
Revenue growth (%): 3.1583480882423314
Rule of 40 score: 22.06635940707148
Financial ratios for RAL — annual report dated 2024-12-31
Total revenue: 2154700000
Gross profit: 1112100000
Operating income: 396500000
Net income: 354600000
Capital expenditures: 25900000
Operating cash flow: 454500000
Depreciation & amortization: 113000000
Net tangible assets: 13200000
Owner earnings: 441700000
Return on net tangible assets (%): 3346.212121212121
Capex to operating income (%): 6.532156368221942
Buffett classification: The Great
Shares outstanding: 111933148
Book value: 3762800000
Debt to equity: 0.01905495907303072
Current ratio: 1.1590781337830243
Quick ratio: 0.6290050590219224
Effective tax rate (%): 18.030513176144243
COGS to revenue (%): 48.38724648442938
R&D to revenue (%): 7.5880633034761225
SG&A to revenue (%): 25.62305657400102
Free cash flow (dilution-adjusted): 395700000
Retained earnings: 0
Inventory turnover: 3.6854012018381055
Receivables turnover: 7.333900612661675
Capitalized R&D asset: 322888000
ROCI (R&D-adjusted, %): 8.871217921590233
Rosenberg metric: -0.047058823529411764
FCF margin (%): 18.364505499605514
Revenue growth (%): -0.04638864405993413
Rule of 40 score: 18.31811685554558